Jose Mathew, DO
Pain Medicine · Lawrenceville, GANPI 1861654659
Payments from drug & device makers
Across 485 payments — averaging $56.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$9K
- Medtronic$7K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Boston Scientific$1K
- Relievant Medsystems, Inc.$1K
- Hydrocision, Inc.$750
- plus $6K from 29 others
What the payments were for
- Consulting fees$7503%
- Speaking & faculty fees$9,02033%
- Travel & lodging$1,8117%
- Food & beverage$15,73158%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 23 | $9,307 |
| Medtronic(2 entities) | 87 | $6,886 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 154 | $1,920 |
| Boston Scientific | 41 | $1,484 |
| Relievant Medsystems, Inc. | 10 | $1,030 |
| Hydrocision, Inc. | 1 | $750 |
| Spinal Simplicity, LLC | 13 | $689 |
| Collegium Pharmaceutical, Inc. | 36 | $611 |
| Nalu Medical, Inc. | 9 | $596 |
| Abbott | 9 | $556 |
| Vertos Medical, Inc. | 6 | $533 |
| Vertiflex, Inc. | 16 | $458 |
| Curonix LLC | 12 | $455 |
| Painteq LLC | 9 | $447 |
| Forte Bio-pharma LLC | 8 | $360 |
| Stryker | 5 | $277 |
| Amgen | 12 | $190 |
| Foundation Fusion Solutions, LLC | 2 | $134 |
| MDD US Operations, LLC | 5 | $104 |
| Arteriocyte Medical Systems, Inc. | 1 | $97 |
| Sentynl Therapeutics, Inc. | 5 | $73 |
| Pfizer | 4 | $65 |
| Bioventus LLC | 2 | $51 |
| Biotronik NRO, Inc. | 1 | $46 |
| Johnson & Johnson | 1 | $37 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| USWM, LLC | 1 | $23 |
| Radius Health, Inc. | 1 | $22 |
| Stimwave Technologies Incorporated | 2 | $21 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $12 |
| Saluda Medical Americas, Inc. | 1 | $11 |
| AstraZeneca | 1 | $11 |
| Electronic Waveform Lab, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZTLido$9,020
- Intracept$3,049
- INTELLIS ADAPTIVESTIM$2,399
- VECTRIS$1,295
- VANTA ADAPTIVESTIM$1,241
- Prolate$767
- TenJet$750
- SpineJet$750
- AlloJet$750
- mild Device Kit$550
- Nalu Neurostimulation System$548
- GENERAL PAIN MANAGEMENT$483
- PROCLAIM$311
- MYSTIM$282
- Nalocet$268
- HA MINUTEMAN G3-R$244
- Superion ISS$233
- PAINTEQ$111
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$108
How this compares
$27,336 in reported general payments places this provider in the 95th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 56 | $162,567 |
| ProlateOxycodone Hcl/Acetaminophen | 62 | $154,064 |
| BelbucaBuprenorphine Hcl | 178 | $118,659 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,560 | $85,319 |
| Buprenorphine | 268 | $64,690 |
| Xtampza ErOxycodone Myristate | 49 | $25,246 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,159 | $23,871 |
| MovantikNaloxegol Oxalate | 51 | $23,389 |
| ZtlidoLidocaine | 41 | $19,643 |
| Pregabalin | 575 | $10,503 |
| Lidocaine | 88 | $6,861 |
| Oxycodone Hcl | 357 | $6,124 |
| Gabapentin | 389 | $4,542 |
| Tramadol Hcl ErTramadol Hcl | 84 | $4,513 |
| Tramadol Hcl | 451 | $4,320 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,920 | $162,56756 claims |
| Forte Bio-pharma LLCProlate | $360 | $154,06462 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $611 | $143,905227 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $9,307 | $19,64341 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 203 pain medicine providers in Georgia.
Other pain medicine in Lawrenceville
- Gabriel MarreroLawrenceville$9K
- An DoLawrenceville$8K
- Adrian BirladeanuLawrenceville$7K
- Arnold WeilMarietta$286K
- Jeffrey GrossmanAtlanta$189K
- Vicente GalanStockbridge$95K
- Rutvij ShahColumbus$86K
- Anthony GrassoMarietta$79K
- Subodh AgrawalAthens$76K
- Maged HamzaGainesville$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.